← Evidence map

Observational studyJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2026

Elexacaftor/tezacaftor/ivacaftor is associated with long-term reduction in use of chronic respiratory therapies in cystic fibrosis.

Scott D Sagel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41320599